<DOC>
	<DOCNO>NCT02117401</DOCNO>
	<brief_summary>To evaluate effect safety mivacurium chloride pediatric patient .</brief_summary>
	<brief_title>A Prospective , Multi-center , Randomized Controlled Study Muscle Relaxation Effect Safety Mivacurium Chloride Pediatric Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Mivacurium</mesh_term>
	<criteria>The parent/guardian must sign parental permission consent document American Society Anesthesiologists ( ASA ) physical status class 13 Elective surgery patient tracheal intubation , operation duration expect longer 30 min longer 120 min ( cleft lip palate , orthopedic , bilateral hernia , bilateral cryptorchidism , hypospadias crack , ear , nose throat surgery , etc ) Age 2 month 14 Years BMI &lt; 18kg/m2 BMI &gt; 31kg/m2 Patients serious respiratory , cardiovascular disease , liver kidney dysfunction [ AST（glutamic oxalacetic transaminase） , ALT ( glutamicpyruvic transaminase ) &gt; 1.5 Normal ; BUN ( blood urea nitrogen ) &gt; Normal ) ] Patients asthma airway hyperresponsiveness , neuromuscular patient disease cachexia Preoperative hemoglobin le 10g/L Hypoproteinemia TP（total protein ) &lt; 45g/L Diabetic patient Patients difficulty airway Patients Known suspected atypical plasma cholinesterase gene homozygous Burn patient Patients serious acidbase imbalance , severe electrolyte imbalance Patients neuromuscular relaxant week Patients prohibit muscle relaxant , allergy component mivacurium Patients participate drug clinical trial 30 day start study Other situation suitable inclusion Blood loss 10 ml/kg surgery</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>